cas 348635-87-0|| where to buy Amisulbrom

Nom du produit:Amisulbrom

IUPAC Name:3-[(3-bromo-6-fluoro-2-methyl-1H-indol-1-yl)sulfonyl]-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide

: CAS：348635-87-0; Formule moléculaire：C13H13BrFN5O4S2; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM430080-100mg	in stock	ƩŁƏ
CM430080-250mg	in stock	ĜǭĨ
CM430080-1g	in stock	ǎĜĜ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 348635-87-0 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:348635-87-0; Formule moléculaire:C13H13BrFN5O4S2; Point de fusion:-; Code SMILES:CN(C)S(=O)(=O)N1C=NC(=N1)S(=O)(=O)N1C(C)=C(Br)C2=CC=C(F)C=C12; Densité:

: Numéro de catalogue:CM430080; Poids moléculaire:466.3; Point d'ébullition:; N° Mdl:MFCD11865361; Stockage:

: Indoles; Indole is a compound of pyrrole and benzene in parallel, also known as benzopyrrole. There are two combinations of pyrrole and benzene, called indole and isoindole, respectively. Many derivatives of indole have physiological and pharmacological activities, and can synthesize vasodilators, antihistamines, antipyretic analgesics, etc. in medicine, so indole is also a very important heterocyclic compound.; indole company; As a indole company,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.